Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Generic drug substitution].

Orly Tamir1, Hillel Halkin, Joshua Shemer

  • 1The Israeli Center for Technology Assessment in Health Care, The Gertner Institute for Epidemiology and Health Policy Research. orlyt@gertner.health.gov.il

Harefuah
|November 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of acute weight gain during regional conflict among individuals with overweight and obesity receiving targeted multidisciplinary care.

Eating and weight disorders : EWD·2026
Same author

A Structured Social Media Health Support Program after Bariatric Surgery.

Applied clinical informatics·2024
Same author

Medicine and Art at IMA and IMAJ.

The Israel Medical Association journal : IMAJ·2024
Same author

Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care.

Diabetes research and clinical practice·2024
Same author

Priority setting for health technology adoption at the national level: Lessons learned over 25 years' experience.

International journal of technology assessment in health care·2023
Same author

Subcutaneous Semaglutide Use for Weight Management: Practice and Attitudes of Physicians in Israel.

The Israel Medical Association journal : IMAJ·2023
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Generic drugs offer a cost-effective alternative to brand-name medications by eliminating expensive clinical trials. Regulatory approval requires demonstrating identical active ingredients and bioequivalence, making generic substitution a key strategy for managing healthcare costs.

Area of Science:

  • Pharmaceutical Sciences
  • Health Economics
  • Regulatory Affairs

Context:

  • Rising healthcare expenditures globally are significantly driven by high prescription drug costs.
  • Governments worldwide are exploring generic drugs as a primary strategy for cost containment in the pharmaceutical market.
  • Brand-name drugs require extensive and costly clinical trials for approval, contributing to their high price.

Purpose:

  • To explain the role and regulatory requirements of generic drug substitution in managing pharmaceutical market costs.
  • To highlight the economic and scientific basis for accepting generic drugs as alternatives to innovator drugs.

Summary:

  • Generic drugs are bioequivalent formulations of brand-name drugs, containing identical active ingredients, strength, and route of administration.

Related Experiment Videos

  • Their development bypasses the need for repetitive, expensive clinical trials, allowing for lower prices.
  • Substitution is permitted only after rigorous demonstration of pharmaceutical and bioequivalence to the reference product.

    • Impact:

    • Generic substitution can significantly reduce healthcare expenditures for patients and healthcare systems.
    • It fosters competition within the pharmaceutical market, driving down overall drug prices.
    • Ensuring the quality and efficacy of generics is crucial for maintaining patient trust and therapeutic outcomes.